Target intelligence / Profile preview

Ankyrin repeat domain 20 family member A3, pseudogene (ANKRD20A3P)

Target
ANKRD20A3P
Molecular classification
Other (Pseudogene, not a protein-coding gene family)
01

Overview

Ankyrin repeat domain 20 family, member A3 pseudogene is a region of human DNA with sequence similarity to the ankyrin repeat domain protein family, but it is classified as a pseudogene due to the absence of functional protein-coding capability. Pseudogenes typically arise through events such as gene duplication or retrotransposition, followed by disabling mutations. While pseudogenes may occasionally play regulatory roles at the RNA level, ANKRD20A3P is not known to encode a functional protein or serve as a molecular target for therapies. Some studies have noted its presence in gene expression analyses, including associations with certain disease states, but there is no evidence of a direct mechanistic function or druggability.

Other names
Ankyrin repeat domain 20 family member A3 pseudogeneANKRD20A3PANKRD20A3Ankyrin repeat domain-containing protein 20A3 pseudogenePutative ankyrin repeat domain-containing protein 20A3Ankyrin repeat domain 20A-related
02

Mechanism of action

None. No mechanisms of action related to drug targeting, as there is no protein product

03

Biological functions

Other (No direct functional protein product; possible role in gene regulation at RNA level like other pseudogenes)
04

Disease associations

Association reported with "Asbestos-related lung carcinoma" (likely from gene expression studies, not a direct causal or mechanistic role)

Beyond the preview

Go deeper on Ankyrin repeat domain 20 family member A3, pseudogene (ANKRD20A3P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ankyrin repeat domain 20 family member A3, pseudogene (ANKRD20A3P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call